Musk Pay Fight Shows Investor Approval Isn't Universal Cure <https://www.law360.com/delaware/articles/2275923?nl_pk=8f2e5a76-bb66-462b-a05a-b234142584d6&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2024-12-20&read_main=1&nlsidx=0&nlaidx=12> The Delaware Court of Chancery's recent denial of a motion revising its prior rescission of Elon Musk's nearly $56 billion compensation package is a reminder of the heightened standard corporate boards must meet in conflicted controller transactions and that stockholder approval doesn't automatically cure fiduciary wrongdoing, say attorneys at A&O Shearman. Decision attached | Read full article » <https://www.law360.com/delaware/articles/2275923?nl_pk=8f2e5a76-bb66-462b-a05a-b234142584d6&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2024-12-20&read_more=1&nlsidx=0&nlaidx=12> | Save to favorites » <https://www.law360.com/delaware/articles/2275923?nl_pk=8f2e5a76-bb66-462b-a05a-b234142584d6&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2024-12-20&read_later=1&nlsidx=0&nlaidx=12>